adenosine diphosphate has been researched along with y 20811 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanamaru, M; Nakashima, M | 1 |
| Kanamaru, M; Mizuno, A; Nakashima, M; Takiguchi, Y; Uematsu, T | 1 |
2 other study(ies) available for adenosine diphosphate and y 20811
| Article | Year |
|---|---|
Phase I study of Y-20811, a new long-acting thromboxane synthetase inhibitor by intravenous administration.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Body Temperature; Drug Evaluation; Half-Life; Humans; Imidazoles; Injections, Intravenous; Middle Aged; Pulse; Respiration; Thromboxane B2; Thromboxane-A Synthase | 1989 |
Phase I study of Y-20811, a new long-acting thromboxane synthetase inhibitor by oral administration.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Administration, Oral; Adult; Blood Pressure; Drug Evaluation; Electrocardiography; Food; Humans; Imidazoles; In Vitro Techniques; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulse; Thromboxane B2; Thromboxane-A Synthase | 1989 |